Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure

Baroreflex control of sympathetic activity is impaired in severe congestive heart failure (CHF), probably causing the marked sympathetic activation typical of this condition. Little information exists, however, as to whether baroreflex impairment and related sympathetic activation also occur in mild...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Circulation (New York, N.Y.) N.Y.), 1995-12, Vol.92 (11), p.3206-3211
Hauptverfasser: GRASSI, G, SERAVALLE, G, MANCIA, G, CATTANEO, B. M, LANFRANCHI, A, VAILATI, S, GIANNATTASIO, C, DEL BO, A, SALA, C, BOLLA, G. B, POZZI, M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3211
container_issue 11
container_start_page 3206
container_title Circulation (New York, N.Y.)
container_volume 92
creator GRASSI, G
SERAVALLE, G
MANCIA, G
CATTANEO, B. M
LANFRANCHI, A
VAILATI, S
GIANNATTASIO, C
DEL BO, A
SALA, C
BOLLA, G. B
POZZI, M
description Baroreflex control of sympathetic activity is impaired in severe congestive heart failure (CHF), probably causing the marked sympathetic activation typical of this condition. Little information exists, however, as to whether baroreflex impairment and related sympathetic activation also occur in mild CHF. We studied 19 patients (age, 57.5 +/- 2.2 years, mean +/- SEM) with CHF in New York Heart Association (NYHA) class III or IV and with a marked reduction in left ventricular ejection fraction (LVEF, 30.1 +/- 1.5% from echocardiography) and 17 age-matched patients with CHF in NYHA class I or II and with an only slightly reduced LVEF (44.9 +/- 3.3%) that never was < 40%. Seventeen age-matched healthy subjects served as control subjects. Primary measurements included beat-to-beat arterial blood pressure (with the Finapres technique), heart rate (from ECG), and postganglionic muscle sympathetic nerve activity (MSNA, from microneurography at the peroneal nerve). Measurements were performed at baseline and during baroreceptor stimulation (intravenous phenylephrine infusion), baroreceptor deactivation (intravenous nitroprusside infusion), and cold-pressor test. Baseline blood pressure was similar in the three groups, whereas heart rate was progressively greater from control subjects to patients with mild and severe CHF, MSNA (bursts per 100 heart beats) increased significantly and markedly from control subjects to patients with mild and severe CHF (47.1 +/- 2.9 versus 64.4 +/- 6.2 and 82.1 +/- 3.4, P < .05 and P < .01, respectively). Heart rate and MSNA were progressively reduced by phenylephrine infusion and progressively increased by nitroprusside infusion. Compared with control subjects, the responses were strikingly impaired in severe CHF patients, but a marked impairment also was seen in mild CHF patients. On average, baroreflex sensitivity in mild CHF patients was reduced by 59.1 +/- 5.5% (MSNA) and 64.8 +/- 4.8% (heart rate). In contrast, reflex responses to the cold-pressor test were similar in the three groups. These results demonstrate that in mild CHF patients the baroreceptor inhibitor influence on heart rate and MSNA is already markedly impaired. This impairment may be responsible for the early sympathetic activation that occurs in the course of CHF.
doi_str_mv 10.1161/01.cir.92.11.3206
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77705042</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>24844004</sourcerecordid><originalsourceid>FETCH-LOGICAL-c508t-6fa25e60b96e29d7d073444e156e37667ec4f0ce837ea3469304442f76ad99893</originalsourceid><addsrcrecordid>eNpdkEtLLDEUhIMoOlf9AS6EIOKux7zTWcqg3gFB8LE1xPRpjaS7x6Rb9N-bwUEudxWK-qo4KYSOKJlTqug5oXMf0tywIuecEbWFZlQyUQnJzTaaEUJMpTlje-hPzm9FKq7lLtrVslacyBl6uv_qVm58hTF47PwYPtwYhh67vsFxyBkPLU7QRvjE-R_SD_2YhohDj7sQm7V-gVzSgF_BpRG3LsQpwQHaaV3McLh599Hj1eXD4m91c3u9XFzcVF6SeqxU65gERZ6NAmYa3RDNhRBApQKuldLgRUs81FyD40IZTorNWq1cY0xt-D46--ldpeF9KpfYLmQPMboehilbrTWRRLACnvwHvg1T6sttllGmeG20LhD9gXwqE5Tv21UKnUtflhK7Ht4SahfLO2tYkXY9fMkcb4qn5w6a38Rm6eKfbnyXvYttcr0P-RdjhorSwr8Bs9aLFg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>212638977</pqid></control><display><type>article</type><title>Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure</title><source>MEDLINE</source><source>American Heart Association Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Journals@Ovid Complete</source><creator>GRASSI, G ; SERAVALLE, G ; MANCIA, G ; CATTANEO, B. M ; LANFRANCHI, A ; VAILATI, S ; GIANNATTASIO, C ; DEL BO, A ; SALA, C ; BOLLA, G. B ; POZZI, M</creator><creatorcontrib>GRASSI, G ; SERAVALLE, G ; MANCIA, G ; CATTANEO, B. M ; LANFRANCHI, A ; VAILATI, S ; GIANNATTASIO, C ; DEL BO, A ; SALA, C ; BOLLA, G. B ; POZZI, M</creatorcontrib><description>Baroreflex control of sympathetic activity is impaired in severe congestive heart failure (CHF), probably causing the marked sympathetic activation typical of this condition. Little information exists, however, as to whether baroreflex impairment and related sympathetic activation also occur in mild CHF. We studied 19 patients (age, 57.5 +/- 2.2 years, mean +/- SEM) with CHF in New York Heart Association (NYHA) class III or IV and with a marked reduction in left ventricular ejection fraction (LVEF, 30.1 +/- 1.5% from echocardiography) and 17 age-matched patients with CHF in NYHA class I or II and with an only slightly reduced LVEF (44.9 +/- 3.3%) that never was &lt; 40%. Seventeen age-matched healthy subjects served as control subjects. Primary measurements included beat-to-beat arterial blood pressure (with the Finapres technique), heart rate (from ECG), and postganglionic muscle sympathetic nerve activity (MSNA, from microneurography at the peroneal nerve). Measurements were performed at baseline and during baroreceptor stimulation (intravenous phenylephrine infusion), baroreceptor deactivation (intravenous nitroprusside infusion), and cold-pressor test. Baseline blood pressure was similar in the three groups, whereas heart rate was progressively greater from control subjects to patients with mild and severe CHF, MSNA (bursts per 100 heart beats) increased significantly and markedly from control subjects to patients with mild and severe CHF (47.1 +/- 2.9 versus 64.4 +/- 6.2 and 82.1 +/- 3.4, P &lt; .05 and P &lt; .01, respectively). Heart rate and MSNA were progressively reduced by phenylephrine infusion and progressively increased by nitroprusside infusion. Compared with control subjects, the responses were strikingly impaired in severe CHF patients, but a marked impairment also was seen in mild CHF patients. On average, baroreflex sensitivity in mild CHF patients was reduced by 59.1 +/- 5.5% (MSNA) and 64.8 +/- 4.8% (heart rate). In contrast, reflex responses to the cold-pressor test were similar in the three groups. These results demonstrate that in mild CHF patients the baroreceptor inhibitor influence on heart rate and MSNA is already markedly impaired. This impairment may be responsible for the early sympathetic activation that occurs in the course of CHF.</description><identifier>ISSN: 0009-7322</identifier><identifier>EISSN: 1524-4539</identifier><identifier>DOI: 10.1161/01.cir.92.11.3206</identifier><identifier>PMID: 7586305</identifier><identifier>CODEN: CIRCAZ</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams &amp; Wilkins</publisher><subject>Adult ; Aged ; Baroreflex - physiology ; Biological and medical sciences ; Blood Pressure - physiology ; Cardiology. Vascular system ; Case-Control Studies ; Cold Temperature ; Female ; Heart ; Heart Failure - diagnosis ; Heart Failure - physiopathology ; Heart failure, cardiogenic pulmonary edema, cardiac enlargement ; Heart Rate - physiology ; Humans ; Male ; Medical sciences ; Middle Aged ; Nitroprusside ; Norepinephrine - blood ; Phenylephrine ; Pressoreceptors - drug effects ; Pressoreceptors - physiopathology ; Sympathetic Nervous System - physiopathology ; Vasoconstrictor Agents ; Vasodilator Agents</subject><ispartof>Circulation (New York, N.Y.), 1995-12, Vol.92 (11), p.3206-3211</ispartof><rights>1996 INIST-CNRS</rights><rights>Copyright American Heart Association, Inc. Dec 1, 1995</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c508t-6fa25e60b96e29d7d073444e156e37667ec4f0ce837ea3469304442f76ad99893</citedby><cites>FETCH-LOGICAL-c508t-6fa25e60b96e29d7d073444e156e37667ec4f0ce837ea3469304442f76ad99893</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3674,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2914063$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7586305$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>GRASSI, G</creatorcontrib><creatorcontrib>SERAVALLE, G</creatorcontrib><creatorcontrib>MANCIA, G</creatorcontrib><creatorcontrib>CATTANEO, B. M</creatorcontrib><creatorcontrib>LANFRANCHI, A</creatorcontrib><creatorcontrib>VAILATI, S</creatorcontrib><creatorcontrib>GIANNATTASIO, C</creatorcontrib><creatorcontrib>DEL BO, A</creatorcontrib><creatorcontrib>SALA, C</creatorcontrib><creatorcontrib>BOLLA, G. B</creatorcontrib><creatorcontrib>POZZI, M</creatorcontrib><title>Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure</title><title>Circulation (New York, N.Y.)</title><addtitle>Circulation</addtitle><description>Baroreflex control of sympathetic activity is impaired in severe congestive heart failure (CHF), probably causing the marked sympathetic activation typical of this condition. Little information exists, however, as to whether baroreflex impairment and related sympathetic activation also occur in mild CHF. We studied 19 patients (age, 57.5 +/- 2.2 years, mean +/- SEM) with CHF in New York Heart Association (NYHA) class III or IV and with a marked reduction in left ventricular ejection fraction (LVEF, 30.1 +/- 1.5% from echocardiography) and 17 age-matched patients with CHF in NYHA class I or II and with an only slightly reduced LVEF (44.9 +/- 3.3%) that never was &lt; 40%. Seventeen age-matched healthy subjects served as control subjects. Primary measurements included beat-to-beat arterial blood pressure (with the Finapres technique), heart rate (from ECG), and postganglionic muscle sympathetic nerve activity (MSNA, from microneurography at the peroneal nerve). Measurements were performed at baseline and during baroreceptor stimulation (intravenous phenylephrine infusion), baroreceptor deactivation (intravenous nitroprusside infusion), and cold-pressor test. Baseline blood pressure was similar in the three groups, whereas heart rate was progressively greater from control subjects to patients with mild and severe CHF, MSNA (bursts per 100 heart beats) increased significantly and markedly from control subjects to patients with mild and severe CHF (47.1 +/- 2.9 versus 64.4 +/- 6.2 and 82.1 +/- 3.4, P &lt; .05 and P &lt; .01, respectively). Heart rate and MSNA were progressively reduced by phenylephrine infusion and progressively increased by nitroprusside infusion. Compared with control subjects, the responses were strikingly impaired in severe CHF patients, but a marked impairment also was seen in mild CHF patients. On average, baroreflex sensitivity in mild CHF patients was reduced by 59.1 +/- 5.5% (MSNA) and 64.8 +/- 4.8% (heart rate). In contrast, reflex responses to the cold-pressor test were similar in the three groups. These results demonstrate that in mild CHF patients the baroreceptor inhibitor influence on heart rate and MSNA is already markedly impaired. This impairment may be responsible for the early sympathetic activation that occurs in the course of CHF.</description><subject>Adult</subject><subject>Aged</subject><subject>Baroreflex - physiology</subject><subject>Biological and medical sciences</subject><subject>Blood Pressure - physiology</subject><subject>Cardiology. Vascular system</subject><subject>Case-Control Studies</subject><subject>Cold Temperature</subject><subject>Female</subject><subject>Heart</subject><subject>Heart Failure - diagnosis</subject><subject>Heart Failure - physiopathology</subject><subject>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</subject><subject>Heart Rate - physiology</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Nitroprusside</subject><subject>Norepinephrine - blood</subject><subject>Phenylephrine</subject><subject>Pressoreceptors - drug effects</subject><subject>Pressoreceptors - physiopathology</subject><subject>Sympathetic Nervous System - physiopathology</subject><subject>Vasoconstrictor Agents</subject><subject>Vasodilator Agents</subject><issn>0009-7322</issn><issn>1524-4539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkEtLLDEUhIMoOlf9AS6EIOKux7zTWcqg3gFB8LE1xPRpjaS7x6Rb9N-bwUEudxWK-qo4KYSOKJlTqug5oXMf0tywIuecEbWFZlQyUQnJzTaaEUJMpTlje-hPzm9FKq7lLtrVslacyBl6uv_qVm58hTF47PwYPtwYhh67vsFxyBkPLU7QRvjE-R_SD_2YhohDj7sQm7V-gVzSgF_BpRG3LsQpwQHaaV3McLh599Hj1eXD4m91c3u9XFzcVF6SeqxU65gERZ6NAmYa3RDNhRBApQKuldLgRUs81FyD40IZTorNWq1cY0xt-D46--ldpeF9KpfYLmQPMboehilbrTWRRLACnvwHvg1T6sttllGmeG20LhD9gXwqE5Tv21UKnUtflhK7Ht4SahfLO2tYkXY9fMkcb4qn5w6a38Rm6eKfbnyXvYttcr0P-RdjhorSwr8Bs9aLFg</recordid><startdate>19951201</startdate><enddate>19951201</enddate><creator>GRASSI, G</creator><creator>SERAVALLE, G</creator><creator>MANCIA, G</creator><creator>CATTANEO, B. M</creator><creator>LANFRANCHI, A</creator><creator>VAILATI, S</creator><creator>GIANNATTASIO, C</creator><creator>DEL BO, A</creator><creator>SALA, C</creator><creator>BOLLA, G. B</creator><creator>POZZI, M</creator><general>Lippincott Williams &amp; Wilkins</general><general>American Heart Association, Inc</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>U9A</scope><scope>7X8</scope></search><sort><creationdate>19951201</creationdate><title>Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure</title><author>GRASSI, G ; SERAVALLE, G ; MANCIA, G ; CATTANEO, B. M ; LANFRANCHI, A ; VAILATI, S ; GIANNATTASIO, C ; DEL BO, A ; SALA, C ; BOLLA, G. B ; POZZI, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c508t-6fa25e60b96e29d7d073444e156e37667ec4f0ce837ea3469304442f76ad99893</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Baroreflex - physiology</topic><topic>Biological and medical sciences</topic><topic>Blood Pressure - physiology</topic><topic>Cardiology. Vascular system</topic><topic>Case-Control Studies</topic><topic>Cold Temperature</topic><topic>Female</topic><topic>Heart</topic><topic>Heart Failure - diagnosis</topic><topic>Heart Failure - physiopathology</topic><topic>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</topic><topic>Heart Rate - physiology</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Nitroprusside</topic><topic>Norepinephrine - blood</topic><topic>Phenylephrine</topic><topic>Pressoreceptors - drug effects</topic><topic>Pressoreceptors - physiopathology</topic><topic>Sympathetic Nervous System - physiopathology</topic><topic>Vasoconstrictor Agents</topic><topic>Vasodilator Agents</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>GRASSI, G</creatorcontrib><creatorcontrib>SERAVALLE, G</creatorcontrib><creatorcontrib>MANCIA, G</creatorcontrib><creatorcontrib>CATTANEO, B. M</creatorcontrib><creatorcontrib>LANFRANCHI, A</creatorcontrib><creatorcontrib>VAILATI, S</creatorcontrib><creatorcontrib>GIANNATTASIO, C</creatorcontrib><creatorcontrib>DEL BO, A</creatorcontrib><creatorcontrib>SALA, C</creatorcontrib><creatorcontrib>BOLLA, G. B</creatorcontrib><creatorcontrib>POZZI, M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>GRASSI, G</au><au>SERAVALLE, G</au><au>MANCIA, G</au><au>CATTANEO, B. M</au><au>LANFRANCHI, A</au><au>VAILATI, S</au><au>GIANNATTASIO, C</au><au>DEL BO, A</au><au>SALA, C</au><au>BOLLA, G. B</au><au>POZZI, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure</atitle><jtitle>Circulation (New York, N.Y.)</jtitle><addtitle>Circulation</addtitle><date>1995-12-01</date><risdate>1995</risdate><volume>92</volume><issue>11</issue><spage>3206</spage><epage>3211</epage><pages>3206-3211</pages><issn>0009-7322</issn><eissn>1524-4539</eissn><coden>CIRCAZ</coden><abstract>Baroreflex control of sympathetic activity is impaired in severe congestive heart failure (CHF), probably causing the marked sympathetic activation typical of this condition. Little information exists, however, as to whether baroreflex impairment and related sympathetic activation also occur in mild CHF. We studied 19 patients (age, 57.5 +/- 2.2 years, mean +/- SEM) with CHF in New York Heart Association (NYHA) class III or IV and with a marked reduction in left ventricular ejection fraction (LVEF, 30.1 +/- 1.5% from echocardiography) and 17 age-matched patients with CHF in NYHA class I or II and with an only slightly reduced LVEF (44.9 +/- 3.3%) that never was &lt; 40%. Seventeen age-matched healthy subjects served as control subjects. Primary measurements included beat-to-beat arterial blood pressure (with the Finapres technique), heart rate (from ECG), and postganglionic muscle sympathetic nerve activity (MSNA, from microneurography at the peroneal nerve). Measurements were performed at baseline and during baroreceptor stimulation (intravenous phenylephrine infusion), baroreceptor deactivation (intravenous nitroprusside infusion), and cold-pressor test. Baseline blood pressure was similar in the three groups, whereas heart rate was progressively greater from control subjects to patients with mild and severe CHF, MSNA (bursts per 100 heart beats) increased significantly and markedly from control subjects to patients with mild and severe CHF (47.1 +/- 2.9 versus 64.4 +/- 6.2 and 82.1 +/- 3.4, P &lt; .05 and P &lt; .01, respectively). Heart rate and MSNA were progressively reduced by phenylephrine infusion and progressively increased by nitroprusside infusion. Compared with control subjects, the responses were strikingly impaired in severe CHF patients, but a marked impairment also was seen in mild CHF patients. On average, baroreflex sensitivity in mild CHF patients was reduced by 59.1 +/- 5.5% (MSNA) and 64.8 +/- 4.8% (heart rate). In contrast, reflex responses to the cold-pressor test were similar in the three groups. These results demonstrate that in mild CHF patients the baroreceptor inhibitor influence on heart rate and MSNA is already markedly impaired. This impairment may be responsible for the early sympathetic activation that occurs in the course of CHF.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>7586305</pmid><doi>10.1161/01.cir.92.11.3206</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0009-7322
ispartof Circulation (New York, N.Y.), 1995-12, Vol.92 (11), p.3206-3211
issn 0009-7322
1524-4539
language eng
recordid cdi_proquest_miscellaneous_77705042
source MEDLINE; American Heart Association Journals; EZB-FREE-00999 freely available EZB journals; Journals@Ovid Complete
subjects Adult
Aged
Baroreflex - physiology
Biological and medical sciences
Blood Pressure - physiology
Cardiology. Vascular system
Case-Control Studies
Cold Temperature
Female
Heart
Heart Failure - diagnosis
Heart Failure - physiopathology
Heart failure, cardiogenic pulmonary edema, cardiac enlargement
Heart Rate - physiology
Humans
Male
Medical sciences
Middle Aged
Nitroprusside
Norepinephrine - blood
Phenylephrine
Pressoreceptors - drug effects
Pressoreceptors - physiopathology
Sympathetic Nervous System - physiopathology
Vasoconstrictor Agents
Vasodilator Agents
title Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T04%3A03%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sympathetic%20activation%20and%20loss%20of%20reflex%20sympathetic%20control%20in%20mild%20congestive%20heart%20failure&rft.jtitle=Circulation%20(New%20York,%20N.Y.)&rft.au=GRASSI,%20G&rft.date=1995-12-01&rft.volume=92&rft.issue=11&rft.spage=3206&rft.epage=3211&rft.pages=3206-3211&rft.issn=0009-7322&rft.eissn=1524-4539&rft.coden=CIRCAZ&rft_id=info:doi/10.1161/01.cir.92.11.3206&rft_dat=%3Cproquest_cross%3E24844004%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=212638977&rft_id=info:pmid/7586305&rfr_iscdi=true